DSM-Firmenich stock expands bio-based resin production in France

dsm-firmenich announced on Monday, November 9, 2026, that production is ramping up at a new hydrogenated bio-based resins unit in Vielle-Saint-Girons, southwestern France. The company made the announcement in a trade release published on its company website.

New capacity for industrial ingredients

The facility was commissioned during the first half of 2026 and manufactures hydrogenated bio-based resins and derivatives for adhesives, coatings, paints and chewing gum. The unit belongs to DRT Industry Ingredients and uses pine-based rosin as its raw material.

dsm-firmenich said the additional capacity will support customers in Europe, North America and Asia. The product lines include DRT Foral and Staybelite, whose applications include electronics, automotive products and road signage. The company highlights low color and stability across significant temperature changes and demanding climatic conditions.

Automated site supports regional network

The Vielle-Saint-Girons site is fully automated. More than 50 companies contributed to the expansion, 90 percent of them local, alongside 120 equipment suppliers. The plant holds ISO 50001 certification and FSSC 22000 certification for chewing-gum resin production, while dsm-firmenich says more than 90 percent of its co-products are valorized.

Stock reference after prior report

DSM-Firmenich stock traded at 105.95 euros on Euronext Amsterdam at 17:20 CET on Tuesday, November 10, 2026. That was 1.07 percent above the 104.83-euro reference in the previous report at 10:10 CET; the period comparison is separate from a daily Xetra comparison.

The company is listed on Euronext Amsterdam and SIX Swiss Exchange. The French expansion adds operating capacity in a specialty-ingredients business, but the release did not provide a financial contribution target for the new unit.

The Swiss market backdrop is covered in current reports on the SMI.

More news and analyses on DSM-Firmenich stock.